Proto Labs, Inc. (NYSE:PRLB) Given Consensus Recommendation of "Moderate Buy" by Analysts

Key Points

• Analysts rate Proto Labs a "Moderate Buy" — consensus from five firms (three buys, two holds) with an average 12‑month price target of $53.33, below the stock's recent open near $64.47.
• Quarterly results topped estimates: Proto Labs reported $0.44 EPS vs. $0.35 expected and $136.49M revenue (up 12.1% YoY), and set Q1 2026 guidance of $0.360–0.440 EPS.
• Insider and institutional activity: Director Michael R. Kenison sold 2,500 shares at $60 (a 6.75% reduction in his holdings); insiders own 1.30% of shares while institutions hold 84.54%.

Proto Labs, Inc. (NYSE:PRLB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $53.3333.

A number of analysts recently issued reports on the company. Zacks Research cut Proto Labs from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 10th. Weiss Ratings reissued a "hold (c-)" rating on shares of Proto Labs in a research report on Thursday, January 22nd.

Insider Transactions at Proto Labs

In related news, insider Michael R. Kenison sold 2,500 shares of Proto Labs stock in a transaction on Friday, February 6th. The stock was sold at an average price of $60.00, for a total transaction of $150,000.00. Following the completion of the sale, the insider owned 34,526 shares of the company's stock, valued at approximately $2,071,560. This trade represents a 6.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.30% of the company's stock.

Institutional Trading of Proto Labs

A number of institutional investors have recently bought and sold shares of PRLB. Amalgamated Bank raised its holdings in Proto Labs by 3.4% during the third quarter. Amalgamated Bank now owns 7,071 shares of the industrial products company's stock valued at $354,000 after buying an additional 235 shares in the last quarter. SG Americas Securities LLC raised its holdings in Proto Labs by 1.7% during the third quarter. SG Americas Securities LLC now owns 21,419 shares of the industrial products company's stock valued at $1,072,000 after buying an additional 349 shares in the last quarter. Horizon Investments LLC raised its holdings in Proto Labs by 3.4% during the fourth quarter. Horizon Investments LLC now owns 11,886 shares of the industrial products company's stock valued at $601,000 after buying an additional 395 shares in the last quarter. Diversified Trust Co. raised its holdings in Proto Labs by 4.7% during the fourth quarter. Diversified Trust Co. now owns 10,495 shares of the industrial products company's stock valued at $531,000 after buying an additional 467 shares in the last quarter. Finally, Federated Hermes Inc. raised its holdings in Proto Labs by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 30,748 shares of the industrial products company's stock valued at $1,556,000 after buying an additional 469 shares in the last quarter. Institutional investors and hedge funds own 84.54% of the company's stock.

Proto Labs Stock Down 0.2%

Shares of Proto Labs stock opened at $64.47 on Monday. The stock has a market cap of $1.53 billion, a PE ratio of 73.26 and a beta of 1.31. The business has a fifty day simple moving average of $60.50 and a 200-day simple moving average of $55.59. Proto Labs has a 12 month low of $33.80 and a 12 month high of $68.91.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings data on Friday, February 6th. The industrial products company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.09. The business had revenue of $136.49 million during the quarter, compared to analyst estimates of $129.07 million. Proto Labs had a return on equity of 3.19% and a net margin of 3.98%.Proto Labs's quarterly revenue was up 12.1% compared to the same quarter last year. During the same period last year, the company earned $0.38 earnings per share. Proto Labs has set its Q1 2026 guidance at 0.360-0.440 EPS. Analysts expect that Proto Labs will post 1.22 EPS for the current fiscal year.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.